Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24094767 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C)
Condition: Elevated LDL-Cholesterol (LDL-C)
Interventions: Drug: ALN-PCS02;   Drug: Sterile Normal Saline (0.9% NaCl)

Indicates status has not been verified in more than two years